Here are four things to know.
1. The Pittsburgh Revolution Fund seeks to raise $200 million, which it plans to invest in drug research teams at the university who are looking to create their own companies.
2. The university’s Drug Discovery Institute will collaborate with the revolution fund to create medications using quantitative systems pharmacology. The method relies on interactive computer models to predict how experimental drugs may affect the progression of various diseases, reports Pittsburgh Post-Gazette.
3. Researchers will focus on developing treatments for breast cancer, neurodegenerative diseases and some liver diseases, according to the report.
4. The Revolution Fund hopes to offer its first grant in early 2018.
More articles on supply chain:
Viewpoint: Supply chain needs more diversity
Mallinckrodt considers sale of generic drug unit: 4 things to know
Medicare patients don’t see benefits of drug rebates, says researchers
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
